Log in to save to my catalogue

The WAVE3/[beta]-catenin oncogenic signaling regulates chemoresistance in triple negative breast can...

The WAVE3/[beta]-catenin oncogenic signaling regulates chemoresistance in triple negative breast can...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A751692529

The WAVE3/[beta]-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

About this item

Full title

The WAVE3/[beta]-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

Publisher

BioMed Central Ltd

Journal title

Breast cancer research : BCR, 2023-03, Vol.25 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background Metastatic breast cancer is responsible for the death of the majority of breast cancer patients. In fact, metastatic BC is the 2nd leading cause of cancer-related deaths in women in the USA and worldwide. Triple negative breast cancer (TNBC), which lacks expression of hormone receptors (ER-[alpha] and PR) and ErbB2/HER2, is especially le...

Alternative Titles

Full title

The WAVE3/[beta]-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A751692529

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A751692529

Other Identifiers

ISSN

1465-5411

DOI

10.1186/s13058-023-01634-3

How to access this item